VANCOUVER, BC — NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF)(“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced… Read More
Global Innovation Clusters join forces to support commercialization of quantum technologies. OTTAWA, ON — /CNW/ — NGen, the industry-led organization leading Canada’s Global Innovation Cluster for Advanced Manufacturing and DIGITAL, Canada’s Global Innovation… Read More
Cytiva and BioCentriq, a New Jersey based cell and gene therapy contract development and manufacturing organization (CDMO,) have been awarded funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals… Read More
VANCOUVER, BC — (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage pharmaceutical development company, is pleased to announce that… Read More
Seven Greater Victoria organizations receive funding to research and commercialize new technologies, create quality jobs, and increase global competitiveness VICTORIA, BC – PacifiCan Across British Columbia, forward-thinking businesses and organizations… Read More
